Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Cambrex Corporation has obtained a Fair Price in its sale to Permira Funds


MILWAUKEE, Aug. 7, 2019 /PRNewswire/ -- Ademi & O'Reilly, LLP is investigating Cambrex (NYSE: CBM) for possible breaches of fiduciary duty and other violations of the law in connection with the sale of Cambrex to Permira.

Click here to learn how to join the action: or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.

Ademi & O'Reilly, LLP alleges Cambrex's financial outlook is improving and yet shareholders will receive only $60 for each share of Cambrex common stock they own. Permira is acquiring Cambrex at a substantial discount. The merger agreement unreasonably limits competing bids for Cambrex by prohibiting solicitation of further bids, and imposing a termination penalty if Cambrex accepts a superior bid. Cambrex insiders will receive millions of dollars as part of change of control arrangements. We are investigating on the conduct of Cambrex's board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for Cambrex.

If you own common stock in Cambrex and wish to obtain additional information, please contact Guri Ademi either at or toll-free: 866-264-3995, or

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.


Ademi & O'Reilly, LLPGuri AdemiToll Free: (866) 264-3995Fax: (414) 482-8001

Cision View original content:

SOURCE Ademi & O'Reilly, LLP

In This Story